Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.3.3 was added to the record history and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a new revision entry (v3.3.2) and removed the previous entry (v3.3.1) in the page's version history, affecting only metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedThe record history now includes a new revision entry v3.3.1 and removes v3.2.0, reflecting metadata updates in the history rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding and operating status disclaimer from the page; the remaining study record content and history are unchanged.SummaryDifference0.6%

- Check53 days agoChange DetectedThe new screenshot shows an extra version entry in the record history and minor formatting changes to the page.SummaryDifference0.1%

- Check82 days agoChange DetectedUpdate includes a critical operating-status notice and a new software version (v3.2.0) replacing the previous v3.1.0.SummaryDifference11%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.